rezdiffra.com 的前十大競爭對手

madrigalpharma.com

What is MASH? Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), is a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. MASH is the leading cause of liver transplants among women in the U.S. and is projected to soon become the leading cause for […]

madrigalpatientsupport.com

If you have been prescribed Rezdiffra™ (resmetirom), Madrigal Patient Support is here to provide guidance at every step.

rezdiffrahcp.com

Explore the baseline characteristics of patients in the MAESTRO-NASH trial. See full Important Safety and Prescribing Information.

everyone.org

Everyone.org

liverdiseasenews.com

Read about Novartis exercising an option to be the developer and exclusive global marketer of Conatus' liver disease therapy emricasan.

accredo.com

accredo is a specialty pharmacy that serves patients with complex and chronic health conditions, including cancer, hepatitis c, hiv, bleeding disorders and multiple sclerosis.

novonordisk.com

We strive for equal opportunities for all employees, and we do our utmost to be able to offer a workplace that’s great to be in.

ozempic.com

See the Ozempic® (semaglutide) dosing schedule, from your first dose to Week 5 and beyond. Learn what to do if you miss a dose. Read Important Safety Information, including Boxed Warning.

pfizerpro.com

Visit the Pfizer for Professionals site to learn more about the Pfizer Oncology Together & Pfizer RxPathways assistance programs for your eligible patients.